In the past week, VCYT stock has gone up by 4.70%, with a monthly gain of 15.00% and a quarterly surge of 35.23%. The volatility ratio for the week is 4.00%, and the volatility levels for the last 30 days are 4.50% for Veracyte Inc. The simple moving average for the past 20 days is 8.29% for VCYT’s stock, with a 49.95% simple moving average for the past 200 days.
Is It Worth Investing in Veracyte Inc (NASDAQ: VCYT) Right Now?
Additionally, the 36-month beta value for VCYT is 1.71. There are mixed opinions on the stock, with 6 analysts rating it as a “buy,” 2 rating it as “overweight,” 2 rating it as “hold,” and 1 rating it as “sell.”
The public float for VCYT is 76.55M and currently, short sellers hold a 3.98% ratio of that float. The average trading volume of VCYT on January 31, 2025 was 808.08K shares.
VCYT) stock’s latest price update
Veracyte Inc (NASDAQ: VCYT) has experienced a rise in its stock price by 3.83 compared to its previous closing price of 44.44. However, the company has seen a gain of 4.70% in its stock price over the last five trading days. zacks.com reported 2025-01-06 that VCYT is gaining shares due to the strength of its Afirma and Decipher tests.
Analysts’ Opinion of VCYT
Many brokerage firms have already submitted their reports for VCYT stocks, with Goldman repeating the rating for VCYT by listing it as a “Neutral.” The predicted price for VCYT in the upcoming period, according to Goldman is $37 based on the research report published on December 05, 2024 of the previous year 2024.
Wolfe Research, on the other hand, stated in their research note that they expect to see VCYT reach a price target of $50. The rating they have provided for VCYT stocks is “Outperform” according to the report published on November 15th, 2024.
UBS gave a rating of “Buy” to VCYT, setting the target price at $43 in the report published on October 16th of the previous year.
VCYT Trading at 10.10% from the 50-Day Moving Average
After a stumble in the market that brought VCYT to its low price for the period of the last 52 weeks, the company was able to rebound, for now settling with 0.30% of gains for the given period.
Volatility was left at 4.50%, however, over the last 30 days, the volatility rate increased by 4.00%, as shares surge +15.35% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +24.57% upper at present.
During the last 5 trading sessions, VCYT rose by +4.70%, which changed the moving average for the period of 200-days by +128.08% in comparison to the 20-day moving average, which settled at $42.61. In addition, Veracyte Inc saw 16.52% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at VCYT starting from EASTHAM KARIN, who sale 10,000 shares at the price of $40.30 back on Jan 02 ’25. After this action, EASTHAM KARIN now owns 18,497 shares of Veracyte Inc, valued at $403,006 using the latest closing price.
KARIN EASTHAM, the Director of Veracyte Inc, proposed sale 10,000 shares at $39.60 during a trade that took place back on Jan 02 ’25, which means that KARIN EASTHAM is holding shares at $396,000 based on the most recent closing price.
Stock Fundamentals for VCYT
Current profitability levels for the company are sitting at:
- 0.03 for the present operating margin
- 0.65 for the gross margin
The net margin for Veracyte Inc stands at -0.02. The total capital return value is set at 0.01. Equity return is now at value -0.83, with -0.77 for asset returns.
Based on Veracyte Inc (VCYT), the company’s capital structure generated 0.02 points at debt to capital in total, while cash flow to debt ratio is standing at 3.36. The debt to equity ratio resting at 0.02. The interest coverage ratio of the stock is 2768.0.
Currently, EBITDA for the company is -49.41 million with net debt to EBITDA at -18.96. When we switch over and look at the enterprise to sales, we see a ratio of 7.81. The receivables turnover for the company is 8.71for trailing twelve months and the total asset turnover is 0.33. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.08.
Conclusion
In conclusion, Veracyte Inc (VCYT) has seen better performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
